Cannabis Bioscience International Holdings (CBIH) Consolidated Net Income (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Consolidated Net Income across 5 years of filings, most recently posting -$104035.0 for Q1 2026.

• Consolidated Net Income for Q1 2026 came in at -$104035.0, up 31.42% year-over-year; the trailing twelve-month figure through Feb 2026 was -$532943.0 (down 76.64% YoY), and the FY2025 annual result was -$557627.0, down 12.17% from the prior year.
• Consolidated Net Income came in at -$104035.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from -$99107.0 in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $18270.0 in Q2 2024 to a low of -$324655.0 in Q1 2023.
• The 5-year median for Consolidated Net Income is -$127871.0 (2025), against an average of -$152913.5.
• Across the five-year window, Consolidated Net Income surged 106.62% in 2024 and plunged 1400.76% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Consolidated Net Income stood at -$219886.0 in 2022, then jumped by 57.02% to -$94512.0 in 2023, then advanced by 27.7% to -$68328.0 in 2024, then slumped by 45.05% to -$99107.0 in 2025, then fell by 4.97% to -$104035.0 in 2026.
• The last three Consolidated Net Income figures came in at -$104035.0 (Q1 2026), -$99107.0 (Q4 2025), and -$92152.0 (Q3 2025), per Business Quant data.